This is a limited company view. Sign up for a Free Trial to see everything.

Complix is a biopharmaceutical company developing Alphabodies, a novel class of biopharmaceuticals.

B2B
Biotechnology
Cleantech
Healthcare
Marketing
Pharmaceuticals
Wind Power

Overview

Location

Diepenbeek

Founded

2008

Employees

26

Stage

Series B

Total funding

$6M

Last funding

5 years ago

Acquisitions

0

Growth score

42

Mindshare score

32

Scoring

Employee Growth

Use Complix's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Complix's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Chief Executive Officer
Chief Technology Officer
Chief Scientific Officer

Similar Companies

MyoKardia

MyoKardia develops novel, small molecule therapeutics that address key clinical needs of patients with genetic heart diseases.
Public|100 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes